Kunitoshi Shigeyasu
7PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 27, 2026
Antigen Remodeling in Colorectal Cancer: How Radiotherapy and Chemotherapy Enhance Immunotherapy Responsiveness.Yuki Matsumi, Kunitoshi Shigeyasu, Toshiaki Takahashi
|Jan 03, 2025
Predictive marker for response to trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer patients.Toshiaki Takahashi, Kunitoshi Shigeyasu, Yoshitaka Kondo
|Jul 04, 2024
<i>BRAF</i>-mutant microsatellite-stable rectal cancer with acquired <i>KRAS</i> mutation leading to drug resistance in liver metastasis.Kunitoshi Shigeyasu, Hideki Yamamoto, Toshiaki Takahashi
|Feb 06, 2023
ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer.Nanako Hata, Kunitoshi Shigeyasu, Yuzo Umeda
|Dec 18, 2022
RNA Editing is a Valuable Biomarker for Predicting Carcinogenesis in Ulcerative Colitis.Kazutaka Takahashi, Kunitoshi Shigeyasu, Yoshitaka Kondo
Pageof 2